Quick Answer
Coherus Oncology, Inc. reported Stockholders Equity of $61.01 million for fiscal year 2025.
Coherus Oncology, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $61.01M | +146.2% |
| 2024 | -$131.99M | +31.8% |
| 2023 | -$193.43M | -40.8% |
| 2022 | -$137.42M | -240.6% |
| 2021 | $97.73M | -65.2% |
| 2020 | $280.97M | +167.1% |
| 2019 | $105.21M | +372.6% |
| 2018 | -$38.59M | -226.4% |
| 2017 | $30.54M | +48.8% |
| 2016 | $20.53M | +430.7% |
| 2015 | -$6.21M | -109.3% |
| 2014 | $66.80M | +168.8% |
| 2013 | -$97.08M | -113.3% |
| 2012 | -$45.50M | -1872.4% |
| 2011 | -$2.31M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $87.77M | +199.8% | -26.7% |
| June 30, 2025 | $119.83M | +242.5% | +165.3% |
| March 31, 2025 | -$183.47M | -124.2% | -39.0% |
| December 31, 2024 | -$131.99M | +31.8% | -50.0% |
| September 30, 2024 | -$87.97M | +34.2% | -4.6% |
| June 30, 2024 | -$84.11M | +51.9% | -2.8% |
| March 31, 2024 | -$81.84M | +58.4% | +57.7% |
| December 31, 2023 | -$193.43M | -40.8% | -44.8% |
- Coherus Oncology, Inc. showed an increase of +146.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Coherus Oncology, Inc.’s stockholders equity has grown by 2744.7% (from -$2.31 million to $61.01 million).
- The most recent figure is from Coherus Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: